Colon cancer survival in the United States by race and stage (2001-2009): Findings from the CONCORD-2 study

Cancer

Volumn 123, Issue , 2017, Pages 5014-5036

  White, Arica ^a   Joseph, Djenaba ^a   Rim, Sun Hee ^a   Johnson, Christopher J ^b   Coleman, Michel P ^c   Allemani, Claudia ^c  

^a CENTERS FOR DISEASE CONTROL AND PREVENTION   (United States)

^b Cancer Data Registry of Idaho   (United States)

^c LONDON SCHOOL OF HYGIENE AND TROPICAL MEDICINE   (United Kingdom)

Author keywords

cancer registries; colon cancer; disparities; population based survival

Indexed keywords

ADOLESCENT; ADULT; AGED; ARTICLE; BLACK PERSON; CANCER EPIDEMIOLOGY; CANCER MORTALITY; CANCER SCREENING; CANCER SURVIVAL; CAUCASIAN; COLON CANCER; CONTROLLED STUDY; FEMALE; HUMAN; INFORMED CONSENT; MAJOR CLINICAL STUDY; MALE; POPULATION RESEARCH; PRIORITY JOURNAL; STANDARDIZATION; TREND STUDY; UNITED STATES; AFRICAN AMERICAN; CANCER STAGING; COLON TUMOR; EPIDEMIOLOGY; ETHNOLOGY; MIDDLE AGED; MORTALITY; PATHOLOGY; REGISTER; STATISTICS AND NUMERICAL DATA; VERY ELDERLY; YOUNG ADULT;

ADOLESCENT; ADULT; AFRICAN AMERICANS; AGED; AGED, 80 AND OVER; COLONIC NEOPLASMS; EUROPEAN CONTINENTAL ANCESTRY GROUP; FEMALE; HUMANS; MALE; MIDDLE AGED; NEOPLASM STAGING; REGISTRIES; UNITED STATES; YOUNG ADULT;

EID: 85037639315     PISSN: 0008543X     EISSN: 10970142     Source Type: Journal    
DOI: 10.1002/cncr.31076     Document Type: Article

References (45)

1. Ferlay J, Soerjomataram I, Ervik M, et al. GLOBOCAN 2012 v1.0, Cancer Incidence and Mortality Worldwide: IARC CancerBase No. 11 [Internet]. Lyon, France: International Agency for Research on Cancer; 2013. Available at: http://globocan.iarc.fr. Accessed April 18, 2016.
2. US Cancer Statistics Working Group. United States Cancer Statistics: 1999-2013 Incidence and Mortality Web-based Report. Atlanta, GA: US Department of Health and Human Services, Centers for Disease Control and Prevention, and National Cancer Institute; 2016. Available at: www.cdc.gov/uscs. Accessed May 25, 2017.
3. Howlader N, Noone AM, Krapcho M, et al, eds. SEER Cancer Statistics Review, 1975-2014, based on November 2016 SEER data submission, posted to the SEER web site April 2017. Bethesda, MD: National Cancer Institute; 2017. Available at: http://seer.cancer.gov/csr/1975_2014/. Accessed June 15, 2017.
4. Edwards BK, Noone AM, Mariotto AB, et al. Annual Report to the Nation on the status of cancer, 1975-2010, featuring prevalence of comorbidity and impact on survival among persons with lung, colorectal, breast, or prostate cancer. Cancer. 2014;120:1290-1314.
5. Allemani C, Coleman MP. Public health surveillance of cancer survival in the United States and world-wide: the contribution of the CONCORD programe. Cancer. 2017;123:4977-4981.
6. Coleman MP, Quaresma M, Berrino F, et al. Cancer survival in 5 continents: a worldwide population-based study (CONCORD). Lancet Oncol. 2008;9:730-756.
7. Allemani C, Weir HK, Carreira H, et al. Global surveillance of cancer survival 1995-2009: analysis of individual data for 25,676,887 patients from 279 population-based registries in 67 countries (CONCORD-2). Lancet. 2015;385:977-1010.
8. White MC, Babcock F, Hayes NS, et al. The history and use of cancer registry data and public health cancer control programs in the United States. Cancer. 2017;123:4969-4976.
9. Young JL, Roffers SD, Ries LAG, Fritz AG, Hurlbut AA, eds. SEER Summary Staging Manual-2000: Codes and Coding Instructions. Bethesda, MD: National Cancer Institute; 2001.
10. Surveillance Epidemiology and End Results (SEER) Program. Collaborative Stage. Available at: http://seer.cancer.gov/tools/collabstaging/. Accessed April 1, 2016.
11. Perme MP, Stare J, Estève J. On estimation in relative survival. Biometrics. 2012;68:113-120.
12. Rachet B, Maringe C, Woods LM, Ellis L, Spika D, Allemani C. Multivariable flexible modelling for estimating complete, smoothed life tables for sub-national populations [serial online]. BMC Public Health. 2015;15:1240.
13. Spika D, Bannon F, Bonaventure A, et al. Life tables for global surveillance of cancer survival (the CONCORD programme): data sources and methods [serial online]. BMC Cancer. 2017;17:159.
14. Corazziari I, Quinn M, Capocaccia R. Standard cancer patient population for age standardising survival ratios. Eur J Cancer. 2004;40:2307-2316.
15. Quaresma M, Coleman MP, Rachet B. Funnel plots for population-based cancer survival: principles, methods and applications. Stat Med. 2014;33:1070-1080.
16. Allemani C, Harewood R, Johnson C, et al. Population-based cancer survival in the United States: data, quality control, and statistical methods. Cancer. 2017;123:4982-4993.
17. Tong L, Ahn C, Symanski E, Lai D, Du XL. Relative impact of earlier diagnosis and improved treatment on survival for colorectal cancer: a US database study among elderly. Cancer Epidemiol. 2014;38:733-740.
18. Gross CP, Andersen MS, Krumholz HM, McAvay GJ, Proctor D, Tinetti ME. Relation between Medicare screening reimbursement and stage at diagnosis for older patients with colon cancer. JAMA. 2006;296:2815-2822.
19. White A, Thompson TD, White MC, et al. Cancer Screening Test Use—United States, 2015. MMWR Morb Mortal Wkly Rep. 2017;66:201-206.
20. Fenton JJ, Tancredi DJ, Green P, Franks P, Baldwin LM. Persistent racial and ethnic disparities in up-to-date colorectal cancer testing in Medicare enrollees. J Am Geriatr Soc. 2009;57:412-418.
21. Rim SH, Joseph DA, Steele CB, et al. Colorectal cancer screening—United States, 2002, 2004, 2006, and 2008. MMWR suppl. 2011;60:42-46.
22. Hines R, Markossian T, Johnson A, Dong F, Bayakly R. Geographic residency status and census tract socioeconomic status as determinants of colorectal cancer outcomes. Am J Public Health. 2014;104:e63-e71.
23. Jemal A, Siegel RL, Ma J, et al. Inequalities in premature death from colorectal cancer by state. J Clin Oncol. 2015;33:829-835.
24. Fleming ST, Mackley HB, Camacho F, et al. Clinical, sociodemographic, and service provider determinants of guideline concordant colorectal cancer care for Appalachian residents. J Rural Health. 2014;30:27-39.
25. Tong L, Ahn C, Symanski E, Lai D, Du XL. Effects of newly developed chemotherapy regimens, comorbidities, chemotherapy-related toxicities on the changing patterns of the leading causes of death in elderly patients with colorectal cancer. Ann Oncol. 2014;25:1234-1242.
26. National Institutes of Health. Adjuvant therapy for patients with colon and rectum cancer. NIH Consens Statement Online. 1990:8:1-25.
27. Abrams TA, Brightly R, Mao J, et al. Patterns of adjuvant chemotherapy use in a population-based cohort of patients with resected stage II or III colon cancer. J Clin Oncol. 2011;29:3255-3262.
28. Laurie JA, Moertel CG, Fleming TR, et al. Surgical adjuvant therapy of large-bowel carcinoma: an evaluation of levamisole and the combination of levamisole and fluorouracil. The North Central Cancer Treatment Group and the Mayo Clinic. J Clin Oncol. 1989;7:1447-1456.
29. Moertel CG, Fleming TR, Macdonald JS, et al. Levamisole and fluorouracil for adjuvant therapy of resected colon carcinoma. N Engl J Med. 1990;322:352-358.
30. Kopetz S, Chang GJ, Overman MJ, et al. Improved survival in metastatic colorectal cancer is associated with adoption of hepatic resection and improved chemotherapy. J Clin Oncol. 2009;27:3677-3683.
31. Lansdorp-Vogelaar I, Kuntz KM, Knudsen AB, van Ballegooijen M, Zauber AG, Jemal A. Contribution of screening and survival differences to racial disparities in colorectal cancer rates. Cancer Epidemiol Biomarkers Prev. 2012;21:728-736.
32. Le H, Ziogas A, Lipkin SM, Zell JA. Effects of socioeconomic status and treatment disparities in colorectal cancer survival. Cancer Epidemiol Biomarkers Prev. 2008;17:1950-1962.
33. White A, Vernon SW, Franzini L, Du XL. Racial disparities in colorectal cancer survival: to what extent are racial disparities explained by differences in treatment, tumor characteristics, or hospital characteristics? Cancer. 2010;116:4622-4631.
34. Henry KA, Sherman RL, McDonald K, et al. Associations of census-tract poverty with subsite-specific colorectal cancer incidence rates and stage of disease at diagnosis in the United States. J Cancer Epidemiol 2014:823484, 2014.
35. White A, Liu CC, Xia R, et al. Racial disparities and treatment trends in a large cohort of elderly African Americans and Caucasians with colorectal cancer, 1991 to 2002. Cancer. 2008;113:3400-3409.
36. Potosky AL, Harlan LC, Kaplan RS, Johnson KA, Lynch CF. Age, sex, and racial differences in the use of standard adjuvant therapy for colorectal cancer. J Clin Oncol. 2002;20:1192-1202.
37. Bach PB, Schrag D, Brawley OW, Galaznik A, Yakren S, Begg CB. Survival of blacks and whites after a cancer diagnosis. JAMA. 2002;287:2106-2113.
38. Yahagi M, Okabayashi K, Hasegawa H, Tsuruta M, Kitagawa Y. The worse prognosis of right-sided compared with left-sided colon cancers: a systematic review and meta-analysis. J Gastrointest Surg. 2016;20:648-655.
39. Meguid RA, Slidell MB, Wolfgang CL, Chang DC, Ahuja N. Is there a difference in survival between right- versus left-sided colon cancers? Ann Surg Oncol. 2008;15:2388-2394.
40. Joseph DA, Redwood D, DeGroff A, Butler EL. Use of evidence-based interventions to address disparities in colorectal cancer screening. MMWR suppl. 2016;65:21-28.
41. Seeff LC, Major A, Townsend JS, et al. Comprehensive cancer control programs and coalitions: partnering to launch successful colorectal cancer screening initiatives. Cancer Causes Control. 2010;21:2023-2031.
42. Meester RG, Doubeni CA, Zauber AG, et al. Public health impact of achieving 80% colorectal cancer screening rates in the United States by 2018. Cancer. 2015;121:2281-2285.
43. US Department of Health and Human Services, Office of Minority Health. National Standards for Culturally and Linguistically Appropriate Services in Health and Health Care (The National CLAS Standards). Rockville, MD: Office of Minority Health; 2017. Available at: https://minorityhealth.hhs.gov/omh/browse.aspx?lvl=2&lvlid=53. Accessed January 6, 2017.
44. Plescia M, Richardson LC, Joseph D. New roles for public health in cancer screening. CA Cancer J Clin. 2012;62:217-219.
45. Weir HK, Stewart SL, Allemani C, et al. Population-based cancer survival (2001-2009) in the United States: findings from the CONCORD-2 study. Cancer. 2017;123:4963-4968.